Literature DB >> 27082010

Diagnostic Challenges in Inflammatory Choroidal Neovascular Membranes.

Reema Bansal1, Pooja Bansal1, Amod Gupta1, Vishali Gupta1, Mangat R Dogra1, Ramandeep Singh1, Deeksha Katoch1.   

Abstract

PURPOSE: To describe the clinical presentations of inflammatory choroidal neovascular membranes (CNVMs) and factors leading to their delayed diagnosis.
METHODS: Retrospective analysis of chart records and digital images of 60 patients (73 eyes) with inflammatory CNVM (January 1998 to December 2013) to obtain demographic and clinical details, particularly the time of the first documentation of inflammatory CNVM by the uveitis specialist, time of its actual appearance on digital images, and the earliest clinical indicators of a CNVM.
RESULTS: In total, 14 (19.2%) eyes had a delayed diagnosis of inflammatory CNVMs, of which five developed significant visual loss. The earliest clinical indicators of CNVM that were overlooked initially due to their subtle appearance, included a tiny subretinal hemorrhage (five eyes), peripapillary halo/fluid/scar (eight eyes), and a subfoveal scar (one eye). The causes of uveitis in these eyes included Vogt-Koyanagi-Harada disease (five eyes, 35.7%), tubercular uveitis (five eyes, 35.7%), idiopathic (three eyes, 21.4%), and sympathetic ophthalmia (one eye, 7.1%). Presence of significant background fundus scarring, sunset glow fundus, visually significant cataract, poorly dilating pupil, media haze due to vitritis, cystoid macular edema, and multiple chorioretinal scars in these eyes probably predisposed to delayed detection of an underlying CNVM.
CONCLUSIONS: A high index of suspicion and comparison of serial fundus photographs to identify the earliest clues of inflammatory CNVMs are important to prevent diagnostic delays and poorer outcomes.

Entities:  

Keywords:  Bevacizumab; choroidal neovascular membrane; diagnosis; inflammation; uveitis

Mesh:

Year:  2016        PMID: 27082010     DOI: 10.3109/09273948.2016.1160128

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  7 in total

1.  Simultaneous bilateral inflammatory choroidal neovascularization in a case of healed serpiginous-like choroiditis.

Authors:  Gitanjli Sood; Ramanuj Samanta; Devesh Kumawat; Prateek Nishant
Journal:  GMS Ophthalmol Cases       Date:  2022-05-20

Review 2.  Enigma of serpiginous choroiditis.

Authors:  Parthopratim Dutta Majumder; Jyotirmay Biswas; Amod Gupta
Journal:  Indian J Ophthalmol       Date:  2019-03       Impact factor: 1.848

3.  Results of Intravitreal Anti-Vascular Endothelial Growth Factor Therapy in Inflammatory Choroidal Neovascularization.

Authors:  Sourour Zina; Sana Khochtali; Alessandro Invernizzi; Imen Ksiaa; Ben Amor Hager; Francesco Viola; Nesrine Abroug; Moncef Khairallah
Journal:  J Curr Ophthalmol       Date:  2021-03-26

4.  Intraocular Tuberculosis: A Challenging Case Mimicking Wet Age-Related Macular Degeneration.

Authors:  Emanuela Interlandi; Francesco Pellegrini; Carlos Pavesio; Marco De Luca; Rocco De Marco; Alessandro Papayannis; Erika Mandarà; Alessandra Cuna; Daniele Cirone; Cristina Ciabattoni; Tatiana Liberali; Antonio Zappacosta; Loredana Latanza
Journal:  Case Rep Ophthalmol       Date:  2021-06-11

Review 5.  An update on inflammatory choroidal neovascularization: epidemiology, multimodal imaging, and management.

Authors:  Aniruddha Agarwal; Alessandro Invernizzi; Rohan Bir Singh; William Foulsham; Kanika Aggarwal; Sabia Handa; Rupesh Agrawal; Carlos Pavesio; Vishali Gupta
Journal:  J Ophthalmic Inflamm Infect       Date:  2018-09-12

6.  Intravitreal Aflibercept as an Adjunct to Systemic Therapy in a Case of Choroidal Neovascular Membrane Associated with Sympathetic Ophthalmia.

Authors:  Ali Osman Saatçi; Ziya Ayhan; Şefik Can İpek; Meltem Söylev Bajin
Journal:  Turk J Ophthalmol       Date:  2018-09-04

7.  Inflammatory Choroidal Neovascular Membranes: Clinical Profile, Treatment Effectiveness, and Visual Prognosis.

Authors:  Gonçalo Carrola; Mário Lima-Fontes; Fernando Falcão-Reis; Luís Figueira; Ângela Carneiro
Journal:  J Ophthalmol       Date:  2021-07-23       Impact factor: 1.909

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.